Abstract
Menin, the protein encoded by the MEN1 gene, is abundantly expressed in the epithelial cells of mammary glands. Here, we found MEN1/menin expression slowly decreased with advancing lactation but increased by the end of lactation. It happened that the number of bovine mammary epithelial cells decreases since lactation, suggesting a role of menin in the control of mammary epithelial cell growth. Indeed, reduction of menin expression through MEN1-specific siRNA transfection in the bovine mammary epithelial cells caused cell growth arrest in G1/S phase. Decreased mRNA and protein expression of Cyclin D1 was observed upon MEN1 knockdown. Furthermore, menin was confirmed to physically bind to the promoter region of Cyclin D1 through a ChIP assay, indicating that menin plays a regulatory role in mammary epithelial cell cycle progression. Moreover, lower expression of MEN1/menin induced increased epithelial cell apoptosis and caused extracellular matrix remodeling by down-regulating its associated genes, such as DSG2 and KRT5, suggesting that menin’s role may also be involved in the control of cell–cell adhesion in normal mammary glands. Taken together, our data revealed an unknown molecular function of menin in epithelial cell proliferation, which may be important in the regulation of lactation behavior of mammary glands.
Electronic supplementary material
The online version of this article (10.1007/s10911-017-9385-8) contains supplementary material, which is available to authorized users.
Keywords: MEN1/menin, Mammary epithelial cells, Cell growth, Cyclin D1
Introduction
Menin, a protein of 610 amino acids encoded by the MEN1 gene, plays an important regulatory role in the metabolism of organisms. Mutations in MEN1 gene and therefore mutant protein menin predispose patients to multiple endocrine neoplasia type 1 (MEN1) syndrome, which is characterized by the occurrence of multiple endocrine tumors, mainly affecting the parathyroid glands, pituitary (anterior lobe) and pancreatic islets [1, 3−3]. These endocrine organs secrete hormones such as prolactin and insulin, which can physiologically modulate the lactation curve pattern of mammary glands. Moreover, prolactin and/or insulin could be downstream factors of menin, which regulates their gene transcription [4, 6−6]. This suggests the existence of a link between MEN1/menin and hormone-dependent tissues [7, 9−9].
Within the mammary gland, menin was recently found to directly interact with estrogen receptor-α (ERα) in a hormone-dependent manner in breast cancer cells [10], thereby regulating the transcription of estrogen-responsive genes in these cells [11]. This finding indicated an important mediator role of menin in mammary gland tissue of dairy cows [12]. Moreover, loss of heterozygosity of MEN1 was found to cause inherited breast-ovarian cancer in humans [13] and hyperplasia of breast (female) and prostate (male) cells in mice [9, 14]. These findings indicated a possible regulatory role of MEN1/menin in cell growth and/or cell cycle progression in mammary gland tissue.
The milk yield and shape of the lactation curve of a dairy cow are determined by the number of mammary epithelial cells and their secretory activity. Nearly all of the cells present in the bovine mammary gland are formed by calving [15]. During early lactation, the number of mammary epithelial cells within the mammary glands is at a peak and then gradually decreases with advancing lactation [15]. The decline in mammary cell numbers during lactation must at least partially account for the decline in milk yield after the peak stage, which occurs approximately 60–90 days after parturition [16]. Accompanying the decline in mammary cell numbers, apoptotic cell death and a degree of cell renewal and lobular-alveolar remodeling are observed [17, 18]. A change in the rate of the decline in cell numbers and/or apoptosis could provide a means of modulating milk yield and mammary gland lactation curve pattern. However, the molecular mechanisms controlling mammary cell growth/survival are poorly defined. It was hypothesized that there were important inherited genetic factors regulating the epithelial cell growth and/or death, therefore making effects on the lactation persistency and milk yield of mammary glands. Hence, the objective of the present investigation was to assess the molecular mechanisms of MEN1/menin in regulating epithelial cell growth in bovine mammary glands. A bovine mammary epithelial cell line, MAC-T, was used as the experimental model [19, 21−21], in addition to mammary gland tissues at different lactation stages.
Results
MEN1/menin Knowdown in Mammary Epithelial Cells
The expression level of MEN1 and it encoded protein menin were investigated during five different lactation stages (including the dry period) in mammary glands of dairy cows, the results indicated both MEN1 mRNA and the menin protein slowly decreased with advancing lactation, but later increased after the peak milk stage through the dry period (or involution stage), with the lowest expression level being observed around the peak lactation stage (55 ± 4.3 days in milk, DIM; supplementary Fig. S1).
To assess the possible regulatory function of the MEN1 gene in the mammary glands of dairy cows, MEN1/menin expression levels were modified in vitro in bovine mammary epithelial cells (MAC-T cells) to mimic the decrease in expression after the initiation of lactation in the mammary gland. In vitro-synthesized siRNAs specific to the bovine MEN1 gene were transfected either separately (sibMEN1-1, sibMEN1-2 or sibMEN1-3) or in combination (sibMEN1-1/2/3, as a siRNA pool) into MAC-T cells (data not shown). sibMEN1-1/2/3 transfection were shown to result in the best knockdown efficiency of MEN1 and menin at 24 h posttransfection via qRT-PCR and western blot detection, respectively. The siRNA pool (sibMEN1-1/2/3) was ultimately used for the following experiments because of the best knockdown level (25.31%±3.86% of the MEN1 mRNA level, Fig. 1a; and 29.26%±11.10% of the menin protein level in untransfected MAC-T cells, respectively; Fig. 1b, c).
Knockdown of MEN1/menin Induces Extracellular Matrix Remodeling
Three independent replicates with lower expression of MEN1/menin were pooled and subjected to high-throughput sequencing (Fig. 2a). These samples exhibited 21.04%±0.24% (n = 3) of MEN1 mRNA and 22.87%±1.30% (n = 3) of the menin protein level found in untransfected MAC-T cells. The results showed 31 genes presented differential expression upon MEN1 knockdown (Fig. 2b), with 19 genes being down-regulated (Fig. 2c) and 12 being up-regulated (Fig. 2d). GO analysis indicated that most down-regulated genes were mainly enriched into extracellular matrix remodeling process upon MEN1 knockdown in mammary epithelial cells (Fig. 2e).
Knockdown of MEN1/menin Arrests Mammary Epithelial Cells in G1/G0 Phase and Delays the G1/S Phase Transition
Upon MEN1 knockdown in mammary epithelial cells, propidium iodide (PI) staining was performed in cells for analysis of the cell phase distribution via flow cytometry, along with the corresponding control cells. The results showed that decreased MEN1 expression substantially increased the percentage of cells by 5.07% in G1/G0 phase (P = 0.026) and decreased the percentage of cells by 4.88% in S phase (P = 0.0019; Fig. 3a, b). To further examine the potential role of menin in controlling epithelial cell growth, we performed immunofluorescence staining of exponentially growing menin-knockdown MAC-T cells using annexin V-FITC and found that the number of annexin V-positive cells was increased in cells with lower menin expression (Fig. 3c, d), indicating cell apoptosis (supplementary Fig. S4). These results suggested that menin suppression causes inhibition of the G1/S transition of bovine mammary epithelial cells.
Menin Down-Regulates of Cyclin D1 Expression
Since the suppression of MEN1/menin expression results in cell growth arrest in the G1/S phase, it was logical to question whether cell cycle regulatory genes are modulated by menin. Hence, the expression of candidate genes that might specifically control the G1/S transition was detected in MAC-T cells upon MEN1 knockdown (Fig. 3a, Supplementary Table S2). The time course MEN1 knockdown induced that the mRNA expression of Cyclin D1 significantly decreased (P < 0.05 for all the three time points), whereas those of CDK4 (P = 0.009 at 48 h), CDK6 (P = 0.03 at 24 h and P = 0.01 at 48 h) and p18 (a G1/S phase-specific cell cycle inhibitor; P = 0.04 at 24 h) increased (Fig. 4a) in various degree upon MEN1/menin knockdown, compared to their corresponding negative controls. At 24 h post-transfection, the expression of Cyclin D1 was further confirmed to be significantly down-regulated in low menin-expressing mammary gland epithelial cells at both the mRNA (Fig. 4b, P = 0.03) and protein (Fig. 4c, d, P = 0.04) levels. These findings were validated by high-throughput sequencing data from epithelial cells, and Cyclin D1 (also named as CCND1) was one of the down-regulated genes identified upon MEN1 knockdown (Fig. 2c).
Menin Associates with the Cyclin D1 Promoter
We hypothesized that menin might associate with promoter regions of Cyclin D1 and repress the transcription of Cyclin D1, obstructing the recruitment of other transcriptional regulators. Hence, a ChIP assay was performed using normal MAC-T cells. We initially designed six amplicons (P1, P2, P3, P4, P5 and P6) to determine whether menin binds to the promoter region of Cyclin D1 (Fig. 5a, Supplementary Table S3). It was found that menin bound to the regions detectable by P1 (P < 0.001), P2 (P < 0.001), P3 (P = 0.02) and P4 (P < 0.001) (Fig. 5b). Based on the promoter sequence of Cyclin D1, up to six TATA-alike boxes and a CCAAT box exist within the P1 region, and a classical GC box with the conserved sequence GGGCGG exists in the P2 region. Thus, menin, known as a scaffold protein directly interacting with a number of different transcription factors [6], may regulate Cyclin D1 transcription, by associating with the RNA polymerase II (Pol II) complex, binding to the promoter region of Cyclin D1 containing TATA boxes, a CCAAT box and GC box elements near the transcription start site. Therefore, menin might regulate the G1/S transition of bovine mammary gland epithelial cells by binding to the Cyclin D1 promoter.
Menin is Abundantly Expressed in Mammary Epithelial Cells
To investigate whether menin is expressesed in epithelial cells in vivo, peak (+ 55) and late (+ 312) milking-stage mammary glands from non-pregnant dairy cows were stained using antibody against menin for immunohistochemistry analysis. Menin expression was detected in both the luminal and basal (myoepithelial) cell layers of the mammary epithelium (Fig. 6a), with much more abundant staining being observed in tissues from late lactation (+ 312) mammary glands than that in peak milk-stage (+ 55) mammary glands (Fig. 6b, P < 0.001).
Discussion
Regulation of the Expression of Cyclin D1 by Menin at G1/S Phase Can Alter the Cell Cycle and Proliferation of Mammary Epithelial Cells
The MEN1 gene encodes menin, a protein that is primarily nuclearly localized and has been shown to interact with a variety of transcriptional factors and other proteins [22, 24−24], suggesting that menin may act as an adaptor protein involved in the regulation of gene expression and, in particular, menin plays a complex role in cell cycle regulation [25]. It has recently been shown that menin mediates the repression of Cyclin B2 expression through physical binding to its promoter and therefore inhibits the G2/M transition and cell proliferation [26]. Moreover, MEN1/menin was previously reported to participate in the regulation of cell cycle progression at G1/S phase [27, 30−30]. Progression through the cell cycle depends on the activity of cyclins (such as Cyclin D1) and/or cyclin-dependent kinase (CDK) inhibitors (such as p18, p21 and p27 proteins), which can cause G1 arrest and termination of DNA synthesis in S-phase [31, 32]. In quiescent rat pituitary somatolactotrope GH4C1 cells, menin blocks the progression from G0/G1 phase to S phase by regulating the expression of the CDK inhibitors p21 and p27 [33]. Indeed, menin has been shown to directly associate with the promoters of p27 and p18 and promotes the methylation of lysine 4 in histone H3 (H3K4) and the expression of these genes [34]. Additionally, menin has been shown to repress the activator of S-phase kinase (ASK)-induced cell proliferation, preventing cells from entering S phase [25, 29, 30]. Thus, menin may play an important regulatory role at G1/S phase by interacting with promoter regions and certain proteins that function as transcription factors.
In this study, we identified a cell cycle progression regulatory role for menin in mammary epithelial cells. Decreased expression levels of menin caused mammary epithelial cell growth arrest at G1/S phase as its physical binding to the promoter region of Cyclin D1, a crucial ligand protein of CDK4/CDK6 enables cell progression from G1 to S phase [28, 35]. In the promoter region of the bovine Cyclin D1 gene where menin potentially binds, there are up to six TATA-like boxes and CCAAT box in the P1 region and a classical GC box with the conserved sequence GGGCGG in the P2 region, which are the preferred promoter elements where RNA polymerase II (Pol II) usually binds. Thus, a decrease in menin may inhibit the binding of Pol II and/or other transcription factors to the promoter, resulting in repression of Cyclin D1 expression. Indeed, accompanying the Cyclin D1 repression observed under reduced menin expression, down-regulation of histone H3 lysine 4 trimethylation (H3K4me3; Supplementary Fig. S2) was found. Simultaneously, the up-regulation of p18 (Supplementary Fig. S3) was found to be associated with lower menin expression, although the detailed underlying mechanisms are not yet clear.
Abundant, but Modulated Expression of Menin in the Mammary Epithelium During Different Lactation Stages Indicates a Potential Regulatory Role of Menin in Epithelial Cell Survival
Menin was found to be abundantly expressed in the cell layers of the mammary epithelium during different stages of lactation, including the dry period (Fig. 6), indicating its potential regulatory role in epithelial cell survival. Notably, menin expression was slowly suppressed with advancing lactation and reached a lower point around the peak milk stage (supplementary Fig. S1, Fig. 7). However, by the involution stage, menin expression was slowly increasing. Provided that a single mammary gland from an individual animal was used to track the expression of MEN1/menin throughout the lactation period, a statistically significant change would be observed. More importantly, the expression model of menin throughout the lactation cycle in mammary glands was found to be negatively correlated with the normal lactation curve, showing that the milk yield continues to increase until peak lactation on days of 60–90, but decline thereafter until involution and/or the dry period.
The number of secretory mammary epithelial cells inside the mammary gland ultimately determines the potential milk yield of an animal. The mammary gland undergoes dramatic functional and metabolic changes during the milking period. For example, the number of epithelial cells slowly declines after lactation begins [15, 36]. The internal molecular regulatory mechanism of this phenomenon has long been a biological conundrum for the mammary biologist. Here, we found that MEN1/menin is the factor that controls the dynamic balance between cell proliferation and cell death in the lactating mammary gland, thus modulating the lactation curve pattern of the mammary gland (Fig. 7).
The decreasing expression of menin after lactation begins may slowly result in growth arrest of mammary epithelial cells through the cell cycle regulator Cyclin D1 and even apoptosis, suggesting that MEN1/menin is one of the internal regulatory molecular mechanisms causing the decline in the number of epithelial cells. Indeed, gene expression profiling of bovine mammary glands suggested that the onset of lactation was accompanied by up-regulation of genes involved in milk synthesis, and by inhibition of genes related to cell proliferation [15, 36, 37]. Cyclin D1 was also found to be significantly down-regulated in early lactation mammary gland tissue compared to late pregnancy tissue (dry stage) [36, 38].
More specifically, with decreasing menin expression, mammary epithelial cells exhibited increased early apoptosis (Fig. 3c, Supplementary Figure S4) and extracellular matrix remodeling activity (Fig. 2e). Genes showing inhibited expression that involved in extracellular matrix activity included extracellular matrix components (keratin filament KRT5, laminin filament LAMB3), cell adhesion molecule (cadherin DSG2), proteolysis and catabolic processes (ubiquitin-related domain, SUMO2; oxidoreductase, BLVRA; hydrolase-like, MEST; peptidase, ECE1) and calcium ion binding (S100 calcium-binding protein A2, S100A2) (Fig. 2c). Interestingly, the role of menin in regulating cell–cell adhesion was also observed in mice with Men1 inactivation-induced lesions in the mammary glands [13] and pancreatic islets [8, 39], although the underlying mechanism requires further investigation. Additionally, and of greater interest, similar groups of gene have been shown to be significantly suppressed in early lactation mammary glands compared with the dry period before parturition according to previous reports [36, 40]. A study in mice found that the communication between mammary epithelial cells and their environment became weak during the lactation period [41]. These results demonstrated that in the period before peak milk, the communications between epithelial cells and their extracellular matrix were slowly weakened [17, 18, 36, 37, 42], with increasing apoptosis of mammary epithelial cells and collapse of extracellular matrix (Fig. 7); these changes then slowly recover in the dry period because of the expression restoration of MEN1/menin, in preparation for the next lactation cycle. Thus, menin is at least one of the internal regulators inside the mammary gland that modulates epithelial cell numbers through the lactation cycle, although other factors are yet to be revealed.
Regarding the modulation of menin expression in mammary epithelial cells at different lactation stages, the reproductive hormone prolactin could be the upstream controller, which inhibits MEN1/menin expression [4, 12, 43]. In bovine mammary gland tissue, the different expression levels of menin during the lactation period may be a consequence of menin responding to the waves of reproductive hormone secretion, thus modulating mammary epithelial cell numbers. In addition to the role of menin in the control of normal mammary cell growth and proliferation, we found that menin can mediate the role of surrounding hormones and energy in milk protein synthesis in epithelial cells through the PI3K/Akt/mTOR pathway [12].
Considering these data together, we hypothesize that MEN1/menin could be one of the primary mediators controlling the growth of epithelial cells through the cell cycle progression factor Cyclin D1, dynamically modulating the lactation persistency and the lactation curve of normal mammary glands. The discovery of this unknown role of menin may shed light on the molecular mechanisms underlying the long-term biological conundrum of declining milk yield after peak lactation in mammary glands. There could be other factors besides of MEN1/menin playing similar regulatory role in mammary glands. This discovery would result in new ideas for adjusting animal milk production and a possible new mechanism in mammary biology.
Materials and Methods
Ethics Statement
All experiments were carried out according to the Regulations for the Administration of Affairs Concerning Experimental Animals published by the Ministry of Science and Technology, China (2004) and were approved by the Animal Care and Use Committee of Shandong Agricultural University, Shandong, China.
Animals and Mammary Gland Tissue Collection
Fifteen healthy multiparous Holstein cows were biopsied for the mammary gland samples at Holstein Cattle Association Jiabao Farm in Shandong province. These cows were not pregnant, with an average parity of 2.67 ± 2.06 and an average weight of 602 ± 19.2 kg. Samples were obtained on lactation days (calving day as day 1) of 4.6 ± 1.5, 55 ± 4.3, 163 ± 6.24, 312 ± 24.6 and during the dry period (36 ± 6.8 days after milking stopped), representing 5 different lactation stages (3 animals for each stage) with a variable developmental status of their mammary glands. Mammary biopsies were collected using the Bard Magnum biopsy system (Bard Peripheral Vascular, Inc., Tempe, AZ, US) as described [12]. The mammary tissue samples were immediately frozen in liquid nitrogen and stored at − 80 °C for subsequent analysis or fixed in a 4% formaldehyde solution for immunohistochemistry. Cows were housed in a free stall barn with constant access to water and feed. Diets were formulated to meet all NRC (2001) recommendations for early- lactation, mid-lactation and/or dry cows using the Cornell-Penn-Miner system (CPM-Dairy, version 3.0.7) to meet the metabolizable energy and protein requirements. Feed was provided ad libitum, and the lactation cows were milked three times daily.
Cell Culture and Transient Transfection Assays
Bovine mammary epithelial cells (MAC-T) were grown in Dulbecco’s modified Eagle’s medium (DMEM), containing 10% fetal bovine serum (FBS), penicillin (100 U/L) and streptomycin (100 mg/L) in a 5% CO2 atmosphere at 37 °C. The cells (5 × 105 cells/well) were pre-seeded in 6-well culture plates in medium without antibiotics at a density of 70–80% confluence at 24 h prior to transfection.
siRNAs specific for the bovine MEN1 gene were designed and synthesized (Ribobio, Guangzhou, China; Supplementary Table S1) and used for MEN1/menin knockdown. MAC-T cells were transfected with 50 nM target-specific pool siRNAs per well using OPTI-MEM® I Medium (Invitrogen, Carlsbad, CA, USA) and Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol, and a non-specific scramble negative control siRNA (Ribobio, Guangzhou, China) transfections were conducted at the same time. The cells were processed for protein and/or RNA isolation at 24 h post-transfection. All of the experiments were performed at least three times for each transfection. Preliminary experiments were conducted under the same condition by using separate and/or combinations of target siRNAs, so as to obtain the best knockdown efficiency.
RNA Isolation and Quantitative Real-Time RT-PCR
Total RNAs were extracted from mammary tissues (about 20 ng) or MAC-T cells (5 × 105 cells) using an RNA extraction kit (Tiangen Biotech, Beijing, China), followed by treatment with DNaseI (Ambion, Austin, Texas, USA). The quality of total RNA was assessed through agarose gel electrophoresis and the calculation of OD260/OD280. Oligo(dT)-primed first-strand cDNA was employed for quantitative real-time RT-PCR (qRT-PCR) using SYBR-Premix Ex Taq II (TaKaRa, Dalian, China) and an Mx3000p cycler (Stratagene, La Jolla, CA, USA). Each CT value was obtained from the averaged CTs of triplicate reactions. The expression level of target gene was normalized to its corresponding internal control β-actin. The data were plotted as fold change over their corresponding controls in MAC-T cells or certain lactation stage in mammary gland tissues. The 2− ΔΔCT method was used to calculate the relative abundance of mRNA. All primer sequences are listed in Supplementary Table S2.
Western Blotting
Total protein were extracted in RIPA lysis buffer (containing 1% PMSF) (Beyotime, Nanjing, China) from MAC-T cells after 24 h of transfection or mammary gland tissues. The proteins (approximately 20 μg of total protein) were separated on a 10% SDS–PAGE gel and transferred onto nitrocellulose membranes using 200 mA of constant current. The western blot was performed as per standard protocols. Primary antibodies against bovine menin (Bethyl Laboratories, Texas, USA), bovine cyclin D1 (Beyotime, Nanjing, China), and β-actin (Beyotime, Nanjing, China) were used at 1:1000 dilution. β-actin was used as the total protein loading control. The HRP-conjugated secondary antibody (Beyotime, Jiangsu, China) was diluted by 1000 as the working solution. Chemiluminescence detection was performed using BeyoECL Plus (Beyotime, Beijing, China). The data are shown as the expression level normalized to their corresponding negative controls. The results are representative of three independent experiments that were used to determine the statistical significance.
High-Throughput Sequencing
RNAs from three independent MEN1-specific siRNA treatments of MAC-T cells collected at 24 h after transfection were extracted and pooled in equal proportions for SE50 high-throughput sequencing to identify the differentially expressed genes (DEG), as were their negative control siRNA treatments. mRNA Sequencing was performed on the Illumina HiSeq 2500 platform. Sequencing libraries were generated using the NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (NEB, USA) following the manufacturer’s recommendations and index codes were added to attribute the sequences to each sample, followed by assessment of library quality using the Agilent Bioanalyzer 2100 system. Raw data (raw reads) in the fastq format were first processed with in-house perl scripts. All downstream analyses were based on high quality clean reads of 10 M. The index for the reference genome was built using Bowtie v2.0.6, and paired-end clean reads were aligned to the reference genome using TopHat v2.0.9. Prior to differential gene expression analysis, for each sequenced library, the read counts were normalized and standardized with the edgeR program package using the method of trimmed mean of M values (TMM). Differential expression analyses of two conditions were performed using the DEGSeq R package (1.12.0). The P values were adjusted via the Benjamini and Hochberg method. A corrected P-value of 1.3E-5, q-value of 0.001 and log2 (fold-change) of 0.3 were set as the threshold for significantly differential expression. Gene Ontology (GO) enrichment analysis of differentially expressed genes was implemented with the GOseq R package, in which gene length bias was corrected. GO terms with corrected P-values of less than 0.05 were considered significantly enriched with differentially expressed genes.
Cell Proliferation and Cell Cycle Analysis
Equal number of MAC-T cells (1 × 106) were transfected with MEN1-specific siRNAs for 24 h as well as the corresponding negative control. The same amount of cells (2.5 × 105) were harvested, fixed and analyzed in Vindelov’s propidium iodide buffer for analysis of the distribution of cell cycle phases (FACSCalibur, BD Biosciences). All of the experiments were performed three times for each transfection.
Cell Apoptosis Assays
Apoptosis levels were detected in MEN1-specific siRNA-treated MAC-T cells (2.5 × 105) at 24 h post-transfection, as well as the untreated and scramble siRNA transfected cells, using an annexin V-FITC Apoptosis kit (Biovision) for immunofluorescence analysis, followed by cell analysis via flow cytometry (FACSCalibur, BD Biosciences) employing Cell Quest Pro software. Aliquots of the same cells (about 5 × 103) were also stained with annexin V (green) and propidium iodide (red) and mounted in DAPI (blue)-containing anti-fade mounting medium. Microscopy and photomicrography were performed with AxioObserver Z1 (Zeiss, Thornwood, NY, USA).
Chromatin Immunoprecipitation (ChIP)
Briefly, 5 × 106 normal MAC-T cells were subjected to cross-linking with 1% formaldehyde, after which the cells were lysed in 1 ml of SDS lysis buffer and sonicated with a Bioruptor sonicator (UCD-200TM-EX, Diagenode, Belgium) to shear the chromatin into 200 – 1,000 bp fragments. The sonicated cell lysates (100 μl of the 1 ml supernatant) and 2 μg of antibodies were used for each immunoprecipitation. Anti-menin (Bethyl Laboratories, Montgomery, TX, USA) and anti-rabbit IgG (Sangon Biotech, Shanghai, China) were used for ChIP analyses. The precipitated DNA was used as template for quantitative real-time PCR using the SYBR-Premix Ex Taq II (TaKaRa, Dalian, China). Primer pairs screening of 1200 bp promoter region of Cyclin D1 gene were designed and synthesized, their detailed information were listed in Supplementary Table S3. For quantitative real-time PCR, CT values for each ChIP were obtained from triplicate reactions. The results were representative of three independent ChIP experiments, showing as the percentage of input by quantifying the amount of chromatin obtained from immunoprecipitation relative to the amount in the input samples.
Immunohistochemistry
Tissues dissected from the mammary glands of cows were fixed in 4% paraformaldehyde and embedded in paraffin. Sections (5 mm thickness) of the tissues were then subjected to standard immunohistochemistry staining. Detection of menin was performed incubating the slides with a rabbit polyclonal antibody (1:100; Bethyl Laboratories, Texas, USA) for 2 h at 37 °C. After the slides were washed, they were treated with HRP-conjugated goat anti-rabbit IgG (1:50; Beyotime, Nanjing, China) for 1 h at 37 °C. Images were captured using a microscope (Leica TCS SP2 AOBS, Germany). Image- Pro Plus (IPP) 6.0 software was used to quantify the mean density of positive-menin signals in mammary epithelial cells by randomly selecting different numbers of microscopic views.
Statistical Analysis
The data are presented as the mean ± S.E.M. of at least three independent experiments. Statistic differences among groups were compared with one-way ANOVA and difference between pair-designed experiments were compared with Student’s t-tests by using SAS8.2 software (SAS Institute Inc., Cary, USA). Significant differences were declared when P-values were < 0.05 (*) or < 0.01 (**).
Electronic supplementary material
Below is the link to the electronic supplementary material.
Acknowledgements
Thanks go to the two anonymous reviewers and the editor, whose comments and suggestions have greatly improved our paper. We would like to thank Dr. Ying Yu (China Agricultural University), Dr. Li Jiang (China Agricultural University) and Dr. Jinming Huang (Research Center of Dairy Cow, Shandong Academy of Agricultural Science) for their helpful discussions about the project and manuscript; Dr. Nana Yang (Taishan Medical University) for her nice support on the flow cytometry analysis; Dr. Fuchang Li (Shandong Agricultural University) for providing the microscope and photographing assistance; Dr. Hui Tang (Shandong Agricultural University) for his nice support on statistical analysis; Ms. Zijuan Qin (Animal Husbandry Laboratory platform of Shandong Agricultural University) for her kind laboratory support on the routine experimental tests. This work was financially supported by the National Natural Science Foundation of China (31402054), the Natural Science Foundation of Shandong (ZR2013CM013), the Key Project of Agricultural Fine Breeding of Shandong Province (2016LZGC030), the Youth Innovation Fund of Shandong Agricultural University (24036), the Modern Agricultural Industry Technology System (CARS-36), Funds of Shandong “Double Tops” Program (SYL2017YSTD08), the Support Program of Tai Mountain Scholar Talent Team for Agricultural Breeding (2014LZ07-04) and the Modern Agricultural Industry Technology System of Shandong Province (SDAIT-12-011-06).
Author Contributions
K.S., X.L. and Z.X. designed and conceived experiments; X.L., H.L. and Q.C. performed the experiments; K.S., X.L., Z.W. and M.Z. analyzed the data; X.L., Z.Y., Y.W., Z.H. and Q.H. contributed reagents/materials/analysis tools; K.S., H.L. and M.Z. wrote the paper.
Compliance with Ethical Standards
Conflict of Interest
None declared.
Footnotes
Kerong Shi and Xue Liu contributed equally to this article.
Electronic supplementary material
The online version of this article (10.1007/s10911-017-9385-8) contains supplementary material, which is available to authorized users.
Contributor Information
Kerong Shi, Email: krshi@sdau.edu.cn.
Zhonghua Wang, Email: zhwang@sdau.edu.cn.
References
- 1.Chandrasekharappa SC, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404–407. doi: 10.1126/science.276.5311.404. [DOI] [PubMed] [Google Scholar]
- 2.Thakker RV. Multiple endocrine neoplasia- syndromes of the twentieth century. J Clin Endocrinol Metab. 1998;83:2617–2620. doi: 10.1210/jcem.83.8.5045. [DOI] [PubMed] [Google Scholar]
- 3.Schussheim DH, et al. Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrin Met. 2001;12(4):173–178. doi: 10.1016/S1043-2760(00)00372-6. [DOI] [PubMed] [Google Scholar]
- 4.Namihira H, et al. The multiple endocrine neoplasia type 1 gene product, Menin, inhibits the human prolactin promoter activity. J Mol Endocrinol. 2002;29:297–304. doi: 10.1677/jme.0.0290297. [DOI] [PubMed] [Google Scholar]
- 5.Sayo Y, et al. The multiple endocrine neoplasia type1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology. 2002;143:2437–2440. doi: 10.1210/endo.143.6.8950. [DOI] [PubMed] [Google Scholar]
- 6.Shi KR, Parekh VI, Swarnava R, Desai SS, Agarwal SK. The embryonic transcription 1 factor Hlxb9 is a Menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators. Endocr Relat Cancer. 2013;20(1):111–122. doi: 10.1530/ERC-12-0077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Crabtree JS, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA. 2001;98:1118–1123. doi: 10.1073/pnas.98.3.1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bertolino P, et al. Pancreatic β-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res. 2003;63:4836–4841. [PubMed] [Google Scholar]
- 9.Seigne C, et al. Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice. BMC Cancer. 2010;10:395–405. doi: 10.1186/1471-2407-10-395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dreijerink KM, et al. Menin links estrogen receptor activiation to histone H3K4 trimethylation. Cancer Res. 2006;66(9):4929–4935. doi: 10.1158/0008-5472.CAN-05-4461. [DOI] [PubMed] [Google Scholar]
- 11.Imachi H, et al. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance. Breast Cancer Res Treat. 2010;122:395–407. doi: 10.1007/s10549-009-0581-0. [DOI] [PubMed] [Google Scholar]
- 12.Li HH, et al. MEN1/Menin regulates milk protein synthesis through mTOR signaling in mammary epithelial cells. Sci Rep. 2017;7:5479. doi: 10.1038/s41598-017-06054-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Papi L, et al. Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report. Cancer Genet Cytogenet. 2009;195(1):75–79. doi: 10.1016/j.cancergencyto.2009.06.019. [DOI] [PubMed] [Google Scholar]
- 14.Seigne C, et al. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands. J Pathol. 2013;229(4):546–558. doi: 10.1002/path.4146. [DOI] [PubMed] [Google Scholar]
- 15.Capuco AV, Wood DL, Baldwin R, Mcleod K, Paape MJ. Mammary cell number, proliferation, and apoptosis during a bovine lactation: relation to milk production and effect of bST. J Dairy Sci. 2001;84:2177–2187. doi: 10.3168/jds.S0022-0302(01)74664-4. [DOI] [PubMed] [Google Scholar]
- 16.Capuco AV, Akers RM, Smith JJ. Mammary growth in Holstein cows during the dry period: quantification of nucleic acids and histology. J Dairy Sci. 1997;80:477–487. doi: 10.3168/jds.S0022-0302(97)75960-5. [DOI] [PubMed] [Google Scholar]
- 17.Furth PA, Bar-Peled U, Li M. Apoptosis and mammary gland involution: reviewing the process. Apoptosis. 1997;2:19–24. doi: 10.1023/A:1026454207398. [DOI] [PubMed] [Google Scholar]
- 18.Stefanon B, Colitti M, Gabai G, Knight CH, Wilde CJ. Mammary apoptosis and lactation persistency in dairy animals. J Dairy Res. 2002;69:37–52. doi: 10.1017/S0022029901005246. [DOI] [PubMed] [Google Scholar]
- 19.Zhou Y, Akers RM, Jiang H. Growth hormone can induce expression of four major milk protein genes in transfected MAC-T cells. J Dairy Sci. 2008;91(1):100–108. doi: 10.3168/jds.2007-0509. [DOI] [PubMed] [Google Scholar]
- 20.Hosseini A, Sharma R, Bionaz M, Loor JJ. Transcriptomics comparisons of Mac-T cells versus mammary tissue during late pregnancy and peak lactation. Adv Dairy Res. 2013;1(1):103. [Google Scholar]
- 21.Suzuki Y, et al. Chemerin is a novel regulator of lactogenesis in bovine mammary epithelial cells. Biochem Bioph Res Commun. 2015;466:283–288. doi: 10.1016/j.bbrc.2015.08.105. [DOI] [PubMed] [Google Scholar]
- 22.Agarwal SK, et al. Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res. 2005;37:369–374. doi: 10.1055/s-2005-870139. [DOI] [PubMed] [Google Scholar]
- 23.Yang Y, Hua X. In search of tumor suppressing functions of menin. Mol Cell Endocrinol. 2007;265–266:34–41. doi: 10.1016/j.mce.2006.12.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Balogha K, Patócsb A, Hunyady L, Rácz K. Menin dynamics and functional insight: take your partners. Mol Cell Endocrinol. 2010;326:80–84. doi: 10.1016/j.mce.2010.04.011. [DOI] [PubMed] [Google Scholar]
- 25.Wu T, Hua XX. Menin represses tumorigenesis via repressing cell proliferation. Am J Cancer Res. 2011;1(6):726–739. [PMC free article] [PubMed] [Google Scholar]
- 26.Wu T, Zhang XL, Huang XH, Yang YQ, Hua XX. Regulation of cyclin B2 expression and cell cycle G2/M transition by menin. J Biol Chem. 2010;285(24):18291–18300. doi: 10.1074/jbc.M110.106575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501–1512. doi: 10.1101/gad.13.12.1501. [DOI] [PubMed] [Google Scholar]
- 28.Ratineau C, et al. Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells. J Biol Chem. 2004;279(23):24477–24484. doi: 10.1074/jbc.M401835200. [DOI] [PubMed] [Google Scholar]
- 29.Schnepp RW, et al. Menin induces apoptosis in murine embryonic fibroblasts. J Biol Chem. 2004;279:10685–10691. doi: 10.1074/jbc.M308073200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Schnepp RW, et al. Functional interaction between tumor suppressor menin and activator of S-phase kinase. Cancer Res. 2004;64:6791–6796. doi: 10.1158/0008-5472.CAN-04-0724. [DOI] [PubMed] [Google Scholar]
- 31.Milne TA, et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA. 2005;102:749–754. doi: 10.1073/pnas.0408836102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ikeo Y, et al. Proliferation-associated expression of the MEN1 gene as revealed by in situ hybridization: possible role of the menin as a negative regulator of cell proliferation under DNA damage. Lab Invest. 2000;80:797–804. doi: 10.1038/labinvest.3780084. [DOI] [PubMed] [Google Scholar]
- 33.Kottemann MC, Bale AE. Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model. DNA Repair. 2009;6:944–952. doi: 10.1016/j.dnarep.2009.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Karnik SK, et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science. 2007;318(5851):806–809. doi: 10.1126/science.1146812. [DOI] [PubMed] [Google Scholar]
- 35.Wu WN, et al. Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells. J Virol. 2011;85(19):10300–10309. doi: 10.1128/JVI.05164-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Finucane KA, McFadden TB, Bond JP, Kennelly JJ, Zhao FQ. Onset of lactation in the bovine mammary gland: gene expression profiling indicates a strong inhibition of gene expression in cell proliferation. Funct Integr Genomics. 2008;8(3):251–264. doi: 10.1007/s10142-008-0074-y. [DOI] [PubMed] [Google Scholar]
- 37.Sorensen MT, Norgaard JV, Theil PK, Vestergaard M, Sejrsen K. Cell turnover and activity in mammary tissue during lactation and the dry period in dairy cows. J Dairy Sci. 2006;89:4632–4639. doi: 10.3168/jds.S0022-0302(06)72513-9. [DOI] [PubMed] [Google Scholar]
- 38.Wang L, et al. Leucyl-tRNA synthetase regulates lactation and cell proliferation via mTOR signaling in dairy cow mammary epithelial cells. Int J Mol Sci. 2014;15(4):5952–5969. doi: 10.3390/ijms15045952. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yan J, et al. Menin interacts with IQGAP1 to enhance intercellular adhesion of beta-cells. Oncogene. 2009;28:973–982. doi: 10.1038/onc.2008.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Rudolph MC, McManaman JL, Hunter L, Phang T, Neville MC. Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution. J Mammary Gland Biol Neoplasia. 2003;8:287–307. doi: 10.1023/B:JOMG.0000010030.73983.57. [DOI] [PubMed] [Google Scholar]
- 41.Lemay DG, Neville MC, Rudolph MC, Pollard KS, German JB. Gene regulatory networks in lactation: identification of global principles using bioinformatics. BMC Syst Biol. 2007;1:56–80. doi: 10.1186/1752-0509-1-56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Gao YY, Lin XY, Shi KR, Yan ZG, Wang ZH. Bovine mammary gene expression profiling during the onset of lactation. PLoS ONE. 2013;8(8):e70393. doi: 10.1371/journal.pone.0070393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Wuescher L, et al. Insulin regulates menin expression, cytoplasmic localization, and interaction with FOXO1. Am J Physiol Endocrinol Metabol. 2011;301(3):E474–E483. doi: 10.1152/ajpendo.00022.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.